Medical Developments International reported AUD55.33M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.


Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.06M 661K Dec/2024
Avita Medical AUD 4.5M 19.42M Dec/2024
Clinuvel Pharmaceuticals AUD 203.01M 24.36M Jun/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Genetic Signatures AUD 54.59M 6.51M Dec/2024
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
Medical Developments International AUD 55.33M 9.6M Dec/2024
Neuren Pharmaceuticals AUD 363.9M 144.75M Dec/2024
Organon & Co USD 733M 191M Jun/2025
Paradigm Biopharmaceuticals AUD 34.06M 10.25M Dec/2024
PYC Therapeutics AUD 55.44M 25.62M Dec/2024
Starpharma Holdings AUD 23.17M 4.94M Dec/2024
Tectonic Therapeutic USD 283.77M 142.99M Jun/2025
Telix Pharmaceuticals AUD 568.21M 164.24M Dec/2024
Viatris USD 15.57B 79.9M Jun/2025
Xeris Pharmaceuticals USD -19300000 10.32M Jun/2025